Pfizer paying 1.5 billion for antibiotics division of AstraZeneca. Please note that these are next-generation tweaks on old antibiotics, not the first new class of antibiotics since 1987*

http://www.fiercebiotech.com/biotech/it-didn-...lnQU9zPSJ9

Quote:

---

Antibiotics have become a major issue in research terms over the past decade as the threat of bacteria becoming resistant to the killing power of older antibiotics has increased, risking millions of deaths from simple infections that have not been fatal for more than half a century.

---

*which is what Brilacidin is, for those new to this site.